Post-registration RMP obligations
Understand your RMP obligations as registrants of therapeutic products and CTGTP.
Implementation of RMP requirements
Registrants are responsible for the implementation and continued compliance with the RMP requirements to characterise or minimise the risks associated with their products. These include routine PV activities and RMA, as well as additional PV activities and RMA stipulated in the product registration conditions. Other information, such as clinical safety study reports and data on local product utilisation, may also be requested by HSA on an ad hoc basis.
Safety notification to HSA
Find out when submission of a safety notification is required for registered therapeutic products and CTGTP.
Submission of PBRER upon HSA's request
Understand the requirements related to the submission of periodic benefit-risk evaluation reports.
HSA-approved educational materials
Understand the requirements related to distribution, revision and discontinuation of HSA-approved educational materials.
HSA-approved controlled access programme or pregnancy prevention programme
Find out what information may be requested for HSA-approved controlled access programme or pregnancy prevention programme.
